Ordenar

Buscar

10/03/2026 Pituitary apoplexy: long-term endocrine and neuro-ophthalmologic outcomes according to management strategy and timing
Guerrero-Pérez, F, Biagetti, B, Araujo-Castro, M, Vicente, A, Serra, G, Rojas, NV, Molero, IG, Villar-Taibo, R, Rodríguez, MDM, Menéndez-Torre, EL, Lamas, C, Gallach, M, García, MDO, Irigaray, A, Simó-Servat, A, Safont, E, Asla, Q, Civantos, S, Iglesias, P. Pituitary apoplexy: long-term endocrine and neuro-ophthalmologic outcomes according to management strategy and timing. ENDOCRINE. 2026; 91(1)DOI:10.1007/s12020-026-04572-0. PMID:41803534. IF:2.900(Q3/6D).
09/03/2026 Gait analysis reveals new outcome measures for monitoring disease progression in individuals with late-onset Pompe disease
Claramunt-Molet, M, Pegueroles, J, Pi-Cervera, A, Rico, M, Idelsohn-Zielonka, S, Domínguez-González, C, Corti, M, Antón, V, Salabarria, SM, Wong, K, James, MK, Byrne, BJ, Díaz-Manera, J. Gait analysis reveals new outcome measures for monitoring disease progression in individuals with late-onset Pompe disease. Journal of NeuroEngineering and Rehabilitation. 2026; 23(1)DOI:10.1186/s12984-026-01898-8. PMID:41803906. IF:5.200(Q1/1D).
09/03/2026 Multidisciplinary Treatment of Inguinoscrotal Sarcomas: Analysis of 39 Cases Treated by Surgical Approach
Samsó, RH, Cabré, LC, Abós, SG, Solerdelcoll, MS, Majercakova, K, García, AS, Alegria, IG, Garrido, MF, Duarte, AM, López, JAG. Multidisciplinary Treatment of Inguinoscrotal Sarcomas: Analysis of 39 Cases Treated by Surgical Approach. Cancers. 2026; 18(5)DOI:10.3390/cancers18050876. PMID:41827809. IF:4.400(Q2/3D).
07/03/2026 Clinical Outcomes and Quality of Life in Older De Novo Kidney Transplant Recipients Under Once-Daily Tacrolimus Formulations: The BITACORA Study
Andrés, A, Jiménez, S, Regidor, MJA, Moreso, F, Crespo, M, Cabañas, NS, Gómez, G, López, V, Corte, MDCD, Fraile-Gómez, P, Lorenzo, I, San Millán, JCR, Cañas, L, Benot, AR, Romero, NC, Diekmann, F, Mendiluce, A, Rivera, CF, Gallego, R, Jiménez, C, Martin-Moreno, PL, Tagarro, EF, Díaz, C, Urcuyo, BM, Roncero, FMG. Clinical Outcomes and Quality of Life in Older De Novo Kidney Transplant Recipients Under Once-Daily Tacrolimus Formulations: The BITACORA Study. CLINICAL TRANSPLANTATION. 2026; 40(3)DOI:10.1111/ctr.70501. PMID:41793258. IF:1.900(Q2/4D).
07/03/2026 From bile to vessels: linking obesity to endothelial dysfunction
Kraler, S, Vilahur, G, Kleinbongard, P. From bile to vessels: linking obesity to endothelial dysfunction. EUROPEAN HEART JOURNAL. 2026; 47(10)DOI:10.1093/eurheartj/ehaf957. PMID:41329862. IF:35.600(Q1/1D).
06/03/2026 Impact of glycemic optimization on myocardial steatosis and cardiac remodeling in patients with newly diagnosed type 2 diabetes: a longitudinal study
Rosales-Rojas, A, Teis, A, Gil-Millan, P, Rossell, J, Pedraz-Petrozzi, B, Vilades, D, Sanchez-Quesada, JL, García-Osuna, A, Mauricio, D, Julve, J, Perez, A, Alonso, N. Impact of glycemic optimization on myocardial steatosis and cardiac remodeling in patients with newly diagnosed type 2 diabetes: a longitudinal study. Cardiovascular Diabetology. 2026; 25(1)DOI:10.1186/s12933-026-03105-3. PMID:41792715. IF:10.600(Q1/1D).
06/03/2026 Erectile dysfunction, type 2 diabetes, and cardiovascular disease: a narrative review and insights from a global real-world cohort analysis
Mores, SM, Franch-Nadal, J, Mauricio, D, Vlacho, B. Erectile dysfunction, type 2 diabetes, and cardiovascular disease: a narrative review and insights from a global real-world cohort analysis. Frontiers In Clinical Diabetes And Healthcare. 2026; 7DOI:10.3389/fcdhc.2026.1781581. PMID:41867241. IF:(Q/D).
04/03/2026 Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial
Català-Moll, F, Blázquez-Bondia, C, Farré-Badia, J, Torres, F, Manzardo, C, Bonfill, E, Curran, A, Domingo, P, Podzamczer, D, Force, L, Falcó, V, Parera, M, Casadellà, M, Miró, JM, Noguera-Julian, M, Paredes, R. Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial. Nature Communications. 2026; 17(1)DOI:10.1038/s41467-026-69846-7. PMID:41781390. IF:15.700(Q1/1D).